Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura

被引:22
作者
Karpman, D
Holmberg, L
Jirgard, L
Lethagen, S
机构
[1] LUND UNIV, DEPT PEDIAT, S-22100 LUND, SWEDEN
[2] LUND UNIV, DEPT COAGULAT DISORDERS, S-22100 LUND, SWEDEN
[3] MALMO GEN HOSP, S-21401 MALMO, SWEDEN
关键词
D O I
10.1038/ki.1996.26
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We studied two brothers with recurrent thrombotic thrombocytopenic purpura (TTP). Platelet retention, measured with a modified Adeplat S glass-bead test, was found to be increased during acute episodes of TTP and during remissions. Values of platelet retention ranged between 57 to 95% (normal range 16 to 34%). The continually elevated values enabled us to investigate which fraction of the patients' blood was responsible for the increased platelet retention and to evaluate the effect of different treatments on this parameter. We found that the patients' plasma increased the retention of normal platelets and of platelets taken from a patient with von Willebrand's disease type III. This activity was located in the cryoprecipitate fraction of plasma. Unusually large von Willebrand factor (VWF) multimers were demonstrated in both children during remission and decreased during relapse. Both fresh frozen plasma (FFP) and a commercial factor VIII/vWF concentrate reduced platelet retention when tested during remission. Treatment of both siblings with FFP or factor VIII/vWF concentrate was beneficial during recurrences. We conclude that the elevated platelet retention is due to a factor in the cryoprecipitate of the childrens' plasma, and that both FFP and factor VIII/vWF concentrate are effective in decreasing platelet retention.
引用
收藏
页码:190 / 199
页数:10
相关论文
共 48 条
[2]  
BRYNES JJ, 1990, AM J HEMATOL, V34, P169
[3]  
BURNS ER, 1982, BLOOD, V60, P1030
[4]   CHRONIC RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA IN INFANTS WITH LARGE VONWILLEBRAND-FACTOR MULTIMERS DURING REMISSION [J].
CHINTAGUMPALA, MM ;
HURWITZ, RL ;
MOAKE, JL ;
MAHONEY, DH ;
STEUBER, CP .
JOURNAL OF PEDIATRICS, 1992, 120 (01) :49-53
[5]   TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA USING VINCRISTINE AND FACTOR-VIII PLASMA-FREE [J].
DELGADOLAMAS, JL ;
ROMEROGARCIA, F ;
RODRIGUEZCARRILLO, J .
AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (01) :77-77
[6]   THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC UREMIC SYNDROME IN 3 SIBLINGS [J].
ELIAS, M ;
HOROWITZ, J ;
TAL, I ;
KOHN, D ;
FLATAU, E .
ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (06) :644-646
[7]   DETERMINATION OF PLASMINOGEN-ACTIVATOR INHIBITOR IN PLASMA USING T-PA AND A CHROMOGENIC SINGLE-POINT POLY-D-LYSINE STIMULATED ASSAY [J].
ERIKSSON, E ;
RANBY, M ;
GYZANDER, E ;
RISBERG, B .
THROMBOSIS RESEARCH, 1988, 50 (01) :91-101
[8]   CRYOSUPERNATANT REGULATES ACCUMULATION OF UNUSUALLY LARGE VWF MULTIMERS FROM ENDOTHELIAL-CELLS [J].
FRANGOS, JA ;
MOAKE, JL ;
NOLASCO, L ;
PHILLIPS, MD ;
MCINTIRE, LV .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (06) :H1635-H1644
[9]   THROMBOTIC THROMBOCYTOPENIC PURPURA - OCCURRENCE 2 YEARS APART DURING LATE PREGNANCY IN 2 SISTERS [J].
FUCHS, WE ;
GEORGE, JN ;
DOTIN, LN ;
SEARS, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (19) :2126-2127
[10]  
HARA T, 1986, AM J PEDIAT HEMATOL, V8, P324